Cardiovascular disease and COVID-19: les liaisons dangereuses.
Eur J Prev Cardiol
; 27(10): 1017-1025, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-32391719
ABSTRACT
Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Cardiovascular Agents
/
Cardiovascular Diseases
/
Cause of Death
/
Coronavirus Infections
/
Pandemics
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Year:
2020
Type:
Article